Project Grant R01AA031815
Award Date
9/23/24
Completion Date
8/31/29
Dollars Obligated
$504K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
This $159,056 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) supports research to investigate the role of a novel dynorphinergic neural circuit in the central amygdala and nucleus accumbens in driving binge-like alcohol drinking behavior during persistent pain and protracted opioid abstinence. The overarching research aims to elucidate the neural mechanisms underlying the co-occurrence of chronic...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) funds research to investigate the effects of adolescent opioid exposure on alcohol-induced hyperalgesia (increased pain sensitivity) in adult mice. The $143,784 award, effective July 30, 2024, supports experiments to test the hypothesis that early-life opioid exposure increases the magnitude of alcohol-induced allodynia (pain from a normally...
This $144,362 Project Grant was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The project aims to elucidate the neural mechanisms underlying the relationship between chronic alcohol exposure and heightened pain sensitivity, with a focus on the role of the parabrachial nucleus (PBN) and neuropeptide Y (NPY) receptor 1 (Y1) signaling. Specifically, the research will determine the activity of PBN Y1...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $424,194 Project Grant under the Alcohol Research Programs (CFDA 93.273) to George Washington University (The) to conduct research on the genetic architecture underlying the comorbidity of alcohol use disorder (AUD) and chronic pain (CP). The project aims to: 1) Estimate the shared genetic variance contributing to AUD and CP phenotypes and the unique genetic variance for each, 2) Determine the extent to which AUD-CP...
The federal Project Grant award R00AA029716, for $497,581.76, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award supports research at Yale University to investigate the neural, physiological, and psychological processes underlying dysfunctions in avoidance learning and pain circuits among individuals with alcohol use disorder (AUD). The primary objectives of the project are to: 1)...
This $194,551 Project Grant was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award will support research at the Medical University of South Carolina (MUSC) to investigate how changes in neural circuits involving parvalbumin interneurons in the prelimbic cortex and ventrolateral periaqueductal gray matter following adolescent alcohol exposure may influence pain sensitivity and related...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will fund a $407,060 research project to examine the impact of chronic alcohol exposure on neural circuit function within the corticostriatal system of rodent models. The 5-year project aims to characterize changes in neural activity within the anterior cingulate cortex, orbitofrontal cortex, and dorsomedial striatum of...
The National Institute on Aging (NIA) awarded a 5-year, $192,851 Project Grant (CFDA 93.866 - Aging Research) to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop, refine, and pilot test an Alcohol Screening, Brief Intervention, and Referral to Treatment (A-SBIRT) protocol tailored for older adults with chronic pain. The project aims to address the gap in clinical care for the millions of older adults with chronic pain who also engage in hazardous...
This federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to identify and validate lysophosphatidic acid (LPA)/LPA receptor (LPAR) signaling as a novel target for the treatment of temporomandibular disorder (TMD) pain. The total award amount is $2,372,115, with a project period from July 2024 to June 2027. The key objectives of the project are to: 1) determine the...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $1,831,197.00 to Emory University to conduct research on the mechanisms underlying nociplastic pain in temporomandibular disorders (TMD). The research aims to develop methods to selectively measure nociceptive sensitivity and distinguish it from pain sensitivity using quantitative sensory testing (QST) and a novel...